Ignite Creation Date:
2025-12-24 @ 7:54 PM
Ignite Modification Date:
2026-03-08 @ 11:21 PM
Study NCT ID:
NCT05982704
Status:
UNKNOWN
Last Update Posted:
2023-08-08
First Post:
2023-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19
Sponsor:
City Clinical Hospital No.52 of Moscow Healthcare Department
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Coronavirus Infections | View |